Spinraza 12 mg solution for injection clinical trials

A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec - RESPOND

This study looks at how well the medicine Spinraza (nusinersen) works for people with Spinal Muscular Atrophy (SMA) who have previously received another treatment called Zolgensma (onasemnogene abeparvovec). Researchers want to see if Spinraza can help improve movement and reduce problems for these patients.